-
Most Recent
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Invest Smarter in the New Biotech Landscape
Big phara and biotech companies are slowly becoming one and the same. Investors can profit from the merge with solid research and timing.
6 Biotech Stocks to Buy Today
Biotech stocks rise and fall on the success of research and getting new products to market. Here are 6 biotechs worth investing into your portfolio.
Will JNJ Rise From the Ashes?
No need to mince words -- Johnson & Johnson is in a pretty good mess right now. But new CEO Alex Gorsky might have the tools to turn things around.
Abbott Laboratories Is Cheaper Than You Think
Abbott Labs financial statements provide information on earnings per share that suggest the stock is undervalued, with a possible P/E ratio better than market
Stock Pick of The Day: Dyax
Dyax is a maker of anti-inflammation drugs, an area with a growing base of patients. While in the early stages of growth, the company shows great promise.
5 Global Stock Buys and 2 Sells
There a number of outstanding opportunities in European stocks, as long as you can do the work to find them. Here are 5 top performers to start with now.
3 New Biotech Buys for Your Portfolio
Three new biotech buys lead the way for additions to your portfolio as we head into April.
Wait for Monsanto to Slide
The stock has much to recommend it -- except its inflated valuation. Here's why you should wait to buy in.
7 Biotech Stocks to Buy
With an aging U.S. population in need of healthcare, biotech stocks will grow with the demographic, providing an excellent chance to buy these 7 stocks.
Amgen’s Stochastic Issues Buy Signal
Amgen has been consolidating with support around its 50-day moving average. Get the target for AMGN.
Here Comes a Bidding War for Amylin
Approval of its diabetes drug has Big Pharma banging on its door, with Bristol-Myers Squibb already said to have offered $3.5 billion, or $22 per share.
4 Biotech ETFs for a Healthy Portfolio
The sector is coming back strong, and a diversified ETF is the best way to play it.
My 2 Favorite Stocks for This Week
These two small caps -- in biotech and microelectronics -- have cutting-edge technology and would make great takeover targets.
Two New Buys to Make April Bloom
These two stocks -- Herbalife and Verisk -- are steadily growing their businesses and look attractive to add to your portfolio.
Generic Versions of Boniva Approved By the FDA
The FDA approved the first generic versions of osteoporosis drug Boniva, allowing manufacturers like Apotex, Orchid Healthcare and Mylan to make the drug.
9 Pharma Buys for a Healthy Portfolio
Their dividends are attractive, and some drugmakers have made great progress in refilling their pipelines.
Why Investors Needn’t Fear the ‘Patent Cliff’
Expiring drug patents can cost pharma stocks billions of dollars, but companies and investors alike can prepare themselves well in advance.
6 Dividend Stocks You Need to Watch
Utilities, a REIT, a pharma, a bond fund and a preferred fund that are worth keeping an eye on.
